Allon Therapeutics, Inc. reported earnings results for the year ended December 31, 2012. For the year, the company reported a net loss of $14,916,297 or $0.12 per share compared to a net loss of $12,774,995 or $0.15 per share for the year ended December 31, 2011, representing an increase in net loss of $2,141,302.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | +9,900.00% |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 14.11K | |
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |
- Stock Market
- Equities
- NPCU.F Stock
- News Allon Therapeutics Inc.
- Allon Therapeutics, Inc. Reports Earnings Results for the Year Ended December 31, 2012